Geode Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.27M Buy
1,662,455
+169,580
+11% +$639K ﹤0.01% 2614
2025
Q1
$6.76M Buy
1,492,875
+46,275
+3% +$210K ﹤0.01% 2512
2024
Q4
$10.2M Buy
1,446,600
+3,564
+0.2% +$25.2K ﹤0.01% 2357
2024
Q3
$11.7M Buy
1,443,036
+66,896
+5% +$545K ﹤0.01% 2288
2024
Q2
$8.8M Buy
1,376,140
+56,968
+4% +$364K ﹤0.01% 2401
2024
Q1
$9.93M Buy
1,319,172
+58,504
+5% +$441K ﹤0.01% 2332
2023
Q4
$11.7M Buy
1,260,668
+80,058
+7% +$741K ﹤0.01% 2243
2023
Q3
$11.9M Buy
1,180,610
+50,870
+5% +$515K ﹤0.01% 2152
2023
Q2
$14.1M Buy
1,129,740
+48,489
+4% +$606K ﹤0.01% 2083
2023
Q1
$12.6M Buy
1,081,251
+33,302
+3% +$389K ﹤0.01% 2108
2022
Q4
$11.1M Buy
1,047,949
+13,842
+1% +$147K ﹤0.01% 2197
2022
Q3
$10M Sell
1,034,107
-60,955
-6% -$591K ﹤0.01% 2255
2022
Q2
$15.9M Buy
1,095,062
+111,550
+11% +$1.62M ﹤0.01% 1932
2022
Q1
$25.7M Buy
983,512
+65,651
+7% +$1.72M ﹤0.01% 1714
2021
Q4
$36.4M Buy
917,861
+56,966
+7% +$2.26M ﹤0.01% 1545
2021
Q3
$43.1M Buy
860,895
+191,007
+29% +$9.55M 0.01% 1402
2021
Q2
$37.2M Buy
669,888
+107,574
+19% +$5.97M 0.01% 1550
2021
Q1
$26.3M Buy
562,314
+32,879
+6% +$1.54M ﹤0.01% 1700
2020
Q4
$23M Buy
529,435
+42,866
+9% +$1.87M ﹤0.01% 1633
2020
Q3
$17.8M Buy
486,569
+191,648
+65% +$7.01M ﹤0.01% 1610
2020
Q2
$8.6M Buy
294,921
+93,720
+47% +$2.73M ﹤0.01% 2012
2020
Q1
$5.26M Buy
201,201
+99,312
+97% +$2.6M ﹤0.01% 2118
2019
Q4
$3.54M Buy
101,889
+9,352
+10% +$324K ﹤0.01% 2658
2019
Q3
$2.93M Buy
+92,537
New +$2.93M ﹤0.01% 2703